Ablation Rates and Long-Term Outcome Following Low-Dose Radioiodine for Differentiated Thyroid Cancer in the West of Scotland: A Retrospective Analysis

K Graham, F Tough, H Belikova, I Wotherspoon… - Endocrine Practice, 2024 - Elsevier
Objective Low-dose radioiodine is an accepted means of remnant ablation in patients with
low-to intermediate-risk differentiated thyroid cancer (DTC) based on the results of several …
相关文章

Ablation Rates and Long-Term Outcome Following Low-Dose Radioiodine for Differentiated Thyroid Cancer in the West of Scotland: A Retrospective Analysis

K Graham, F Tough, H Belikova… - … : official journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Objective Low-dose radioiodine is an accepted means of remnant ablation in patients with
low-to intermediate-risk differentiated thyroid cancer (DTC) based on the results of several …
[HTML] endocrinepractice.org

[HTML][HTML] Ablation Rates and Long-Term Outcome Following Low-Dose Radioiodine for Differentiated Thyroid Cancer in the West of Scotland: A Retrospective Analysis

K Graham, F Tough, H Belikova… - Endocrine …, 2024 - endocrinepractice.org
Objective Low-dose radioiodine is an accepted means of remnant ablation in patients with
low-to intermediate-risk differentiated thyroid cancer (DTC) based on the results of several …

Ablation rates and long term outcome following low dose radioiodine for differentiated thyroid cancer in the West of Scotland: a retrospective analysis.

K Graham, F Tough, H Belikova… - … : Official Journal of the …, 2024 - europepmc.org
Low dose radioiodine is an accepted means of remnant ablation in patients with low to
intermediate risk differentiated thyroid cancer (DTC) based on the results of several Phase III …

Ablation rates and long term outcome following low dose radioiodine for differentiated thyroid cancer in the West of Scotland: a retrospective analysis

K Graham, F Tough, H Belikova… - Endocrine …, 2024 - discovery.dundee.ac.uk
Objective: Low-dose radioiodine is an accepted means of remnant ablation in patients with
low-to intermediate-risk differentiated thyroid cancer (DTC) based on the results of several …